Author's posts
FDA Gives Emergency Approval To Covid-19 Treatment That Combines Eli Lilly Arthritis Drug With Remdesivir
This is the first drug combination given emergency approval by the FDA for the coronavirus.
Eli Lilly Covid-19 Antibody Treatment Granted Emergency FDA Authorization
“This emergency authorization allows us to make bamlanivimab available as a COVID-19 treatment for recently diagnosed, high-risk patients—adding a valuable tool for doctors fighting the now-increasing burden of this global pandemic,” Eli Lilly CEO Davi…
Regeneron Releases Positive Trial Data For Covid Antibody Treatment As It Seeks Emergency FDA Authorization
Data from 524 patients in a randomized, double-blind trial showed the antibody treatment “significantly reduced viral load” and patient medical visits,” Regeneron said.
West Coast Covid-19 Pact: States Vow To Review Vaccine Before Distribution
California, Washington, Oregon and Nevada will independently review a vaccine after FDA approval.
FDA Approves Remdesivir For Covid-19 Treatment
The drug was previously granted emergency use authorization, not full approval.
Trump’s Doctor Says The President Now Tests Negative For Covid-19—But Not With A PCR Test
Trump held his first public event since returning from the hospital for the coronavirus on Saturday.
In First Video From Hospital, Trump Says He Feels ‘Much Better,’ But Next Few Days Will Be ‘The Real Test’
“I came here, wasn’t feeling so well. I feel much better now.”
White House: Trump Heading To Walter Reed Hospital
Trump also took a dose of an experimental antibody cocktail that hasn’t yet been given emergency use authorization by the FDA.
Internal Memo: Pfizer CEO Slams Politicization Of Vaccine Development During Presidential Debate
“I was disappointed that the prevention for a deadly disease was discussed in political terms rather than scientific facts,” CEO Albert Bourla said.
Illness In Paused AstraZeneca Trial Likely Wasn’t Caused By Vaccine, Oxford University Says
“After independent review, these illnesses were either considered unlikely to be associated with the vaccine or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine.”
